TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/3/23 20:01 | 8/1/23 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hopfner Robert Lorne | MA | D | P | 4,000 | 4.80 | 0 | 833 | 113 | 1,572 | I | |||||||||||||||
5/15/23 17:06 | 5/11/23 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hopfner Robert Lorne | MA | D | P.m | 2,850 | 6.36 | 0 | 448 | 14 | 3,662 | I | |||||||||||||||
3/30/23 17:46 | 3/29/23 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hopfner Robert Lorne | MA | D | P | 1,564 | 4.54 | 0 | 345 | 12 | 3,214 | I | |||||||||||||||
3/29/23 19:30 | 3/27/23 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hopfner Robert Lorne | MA | D | P.m | 841 | 4.05 | 0 | 208 | 8 | 2,869 | I | |||||||||||||||
4/20/22 16:05 | 4/19/22 | INZY | Inozyme Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Hopfner Robert Lorne | MA | D | P | 3,948 | 3.69 | 0 | 1,070 | 67 | 2,661 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |